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Introduction
Adipose tissue plays an intriguing role in the endocrine
system by producing adipokines [1]. In patients with
obesity, metabolic syndrome, and type 2 diabetes
(DM2), insulin resistance is influenced by adipokines [1].
From a metabolic point of view, the stress response
caused by surgical injury imitates the diabetic state.
Stereotypical endocrine-metabolic and inflammatory
reactions result in catabolism and pronounced insulin
resistance, which is related to outcome [2].
Objectives
Three adipokines including angiopoietin-like protein 2
(ANGPTL2), CXC-chemokine ligand 5 (CXCL5), and Vis-
fatin that are known to interact with insulin resistance [1]
were evaluated in patients undergoing cardiac surgery.
Methods
Sixty-six patients scheduled for elective aortocoronary
bypass surgery and/or valve repair were consecutively
enrolled receiving standardized perioperative care.
Serum adipokine concentrations were assessed before
anesthesia induction as baseline values, upon arrival on
the intensive care unit, on the first (POD1) and third
(POD3) day postoperatively.
Results
Patients’ baseline characteristics are shown in table 1.
ANGPTL2 increased from baseline until POD1 and
remained elevated on POD3 (table 2). In contrast,
CXCL5 levels decreased during surgery and returned to
baseline by POD3. Visfatin levels increased during sur-
gery, showed a decrease by POD1 only to increase again
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Table 1
Variable All patients (66) Non-diabetics (46) Diabetics (20)
Sex (M/F) 45/21 33/13 12/8
Age (yrs) 65.5 ± 13 64 ± 14 68.7 ± 9.8
ASA (2/3/4) 13/46/7 9/35/2 4/11/5
BMI (kg/m2) 27.5 ± 4.4 26.4 ± 4.2 30.1 ± 3.9
HbA1c (%) 6.3 ± 0.9 5.9 ± 0.4 7.3 ± 1.1
EuroSCORE 4.8 ± 4.6 4.0 ± 2.6 6.5 ± 7.1
SAPS II Score 28.3 ± 8.3 27.7 ± 8.7 29.9 ± 7.1
Type of surgery AKB/valve/multiple 23/22/21 16/17/14 7/5/7
Duration of surgery (min) 212.5 ± 47.2 206.2 ± 46.2 226.8 ± 47.5
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by POD3. DM2 patients appear to exhibit a marked Vis-
fatin increase during surgery, as well as a pronounced
increase in CXCL5 from POD1 to POD3.
Conclusions
This exploratory study assessed for the first time the
perioperative levels of ANGPTL2, CXCL5, and Visfatin.
Further studies are warranted to correlate adipokine
concentrations with insulin resistance and surgical out-
comes and to investigate the potential role of adipokines
as biomarkers or therapeutic targets.
Grant acknowledgment
Research Fond, Department of Anesthesia and Surgical Intensive Care,
University Hospital Basel, Switzerland.
Authors’ details
1University Hospital Basel, Department of Anesthesia & Surgical Intensive
Care, Basel, Switzerland. 2McGill University, School of Dietetics and Human
Nutrition, Montreal, Canada. 3University Hospital Basel, Department of
Cardiac Surgery, Basel, Switzerland.
Published: 26 September 2014
References
1. Ouchi N, et al: Adipokines in inflammation and metabolic disease. Nat
Rev Immunol 2011, 11:85-97.
2. Coursin DB, et al: Perioperative diabetic and hyperglycemic management
issues. Crit Care Med 2004, 32:S116-25.
doi:10.1186/2197-425X-2-S1-P46
Cite this article as: Meyer et al.: 0714. Interaction between adipokines
and the metabolic stress response: angpt l2 cxcl5 and visfatin in
patients undergoing cardiac surgery. Intensive Care Medicine Experimental
2014 2(Suppl 1):P46.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article




POD 1 POD 3
ANGPTL2 (ng/
ml)
All 66 ± 36 86 ± 30 96 ± 35 90 ± 35
Non-
DM2
71 ± 38 85 ± 32 97 ± 36 90 ± 38
DM2 56 ± 29 87 ± 26 93 ± 31 90 ± 30
























Visfatin (ng/ml) All 4.9 ± 2.5 13.2 ±
7.1
7.7 ± 3.4 12.6 ± 5.8
Non-
DM2
4.6 ± 2.4 12.5 ±
7.2
7.6 ± 3.6 12.6 ± 6.2
DM2 5.3 ± 3.2 14.6 ±
6.9
7.8 ± 2.9 12.5 ± 4.9
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